Polymorphism in opioid gene affects breast cancer survival

This article originally appeared here.
Polymorphism in Opioid Gene Affects Breast Cancer Survival
Polymorphism in Opioid Gene Affects Breast Cancer Survival

(HealthDay News) -- Genotype at the A118G polymorphism of the µ-opioid receptor gene is associated with breast cancer-specific mortality, according to a study published in the April issue of Anesthesiology.

Preclinical studies suggest that opioids may have a tumor-promoting effect. To investigate the association between common polymorphisms, including the A118G polymorphism, in the µ-opioid receptor gene and breast cancer survival, Andrey V. Bortsov, M.D., Ph.D., of the University of North Carolina at Chapel Hill, and colleagues followed 2,039 women diagnosed with breast cancer in 1993 to 2001, through 2006. The women, aged 23 to 74 years, were genotyped using the TaqMan platform.

The researchers found that patient genotype at A118G correlated with breast cancer-specific mortality at 10 years. Significantly decreased breast cancer-specific mortality was seen for women with one or more copies of the G allele. The correlation was seen only for invasive cases and the effect size seemed to increase with clinical stage. Compared with the A/A genotype, significantly decreased mortality was seen for women with the A/G and G/G genotypes, after adjusting for age and ethnicity (hazard ratios 0.57 and 0.32, respectively).

"The results of this study provide support for the hypothesis that endogenous and/or exogenous opioids, acting via the µ-opioid receptor, may influence cancer outcomes," the authors write.

Abstract
Full Text

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs